AffyImmune Therapeutics
ID: 7642478AffyImmune Therapeutics is a clinical-stage biotechnology company focusing on the optimization of CAR T cells for the treatment of solid tumors using thier Tune & Track platform.
1
Funding Rounds
$30.0m
Money raised
Recent Funding Rounds
Overview
AffyImmune Therapeutics is a clinical-stage biotechnology company focusing on the optimization of CAR T cells for the treatment of solid tumors using thier Tune & Track platform.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ga** So** |
|
- | |
| Mo***** Ji* | - | - |
Funding series
Funding Series Analysis
The company AffyImmune Therapeutics has raised a total of $30m in funding over 1 rounds.
Key Insights:
- AffyImmunee Therapeutics Series A+ round, October 2021: $30m
Industries
AffyImmune Therapeutics is active in the following industries: